Bariatric surgeries led to about five-times more weight loss than weekly injections of popular GLP-1 drugs, according to data ...

If weight loss feels impossible despite your best efforts, hidden survival responses may be blocking progress. Learn how to ...

Shares of Scholar Rock climbed after the company disclosed what it called positive results from a Phase 2 study assessing its drug for weight loss. Shares rose 12% to $35.01 in pre-market trading ...

Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose ...

Eli Lilly's Zepbound is the first and only approved dual GLP-1/GIP agonist, and Lilly is also working on its own triple ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Although GLP-1 drugs make headlines for vision risks, other weight-loss medications carry their own eye-related side effects.

Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.

Doctors highlight new weight-loss medications, early-onset diabetes, and pregnancy-related risks during Diabetes Awareness ...

A sustained drop in body mass index during midlife is associated with a 19% reduction in all-cause mortality over a 35-year ...